Express Pharma
Home  »  Deals  »  Healthcare industry reported 119 deals worth $10.8 billion in March 2021

Healthcare industry reported 119 deals worth $10.8 billion in March 2021

Deal value decreased by 66.7 per cent in March 2021, compared to February 2021

0 292
Read Article

In March 2021, the healthcare industry reported 119 deals worth $10.8 billion as compared to the last 12-month average (March 2020 to February 2021) of 94 deals worth $20 billion.

Amgen Inc, a biopharmaceutical company, to acquire Five Prime Therapeutics Inc, a clinical-stage biotechnology company for $38 per share in cash, representing an equity value of approximately $1,900 million; Altaris Capital Partners, LLC, a private equity firm, to acquire Generic Rx Pharmaceuticals business of Perrigo Company plc for $1,550 million in cash; and Abu Dhabi Developmental Holding Company PJSC to acquire Amoun Pharmaceutical Company S.A.E., a company engaged in the development, manufacturing, marketing, distribution, and export of human pharmaceutical and animal health products for $740 million are the three major deals reported in March 2021.

Deal Date

Acquirer (s) Target

Deal Value ($ m)

4-Mar-21 Amgen Inc (US) Five Prime Therapeutics Inc (US) 1,900.0
1-Mar-21 Altaris Capital Partners LLC (US) Generic Rx Pharma Business (Ireland) 1,550.0
24-Mar-21 Abu Dhabi Developmental Holding Company PJSC (United Arab Emirates) Amoun Pharmaceutical Company SAE (Egypt) 740.0
31-Mar-21 Amgen Inc (US) Rodeo Therapeutics Corp (US) 721.0
30-Mar-21 Nordic Capital Ltd (United Kingdom) Leo Pharma AS (Denmark) 536.0

Venture Capital Investments Increased by 45.9 per cent in March 2021, compared to February 2021

The healthcare industry reported 187 venture capital (VC) deals worth $8.1billion in March 2021, compared to the last 12-month average (March 2020 to February 2021) of 140 deals worth $4 billion.

ElevateBio LLC, raising $525 million in series C round of financing to expand and advance its technology to accelerate the production and development of life-saving cell and gene therapies; Insitro Inc, raising $400 million in series C  round of financing to reshape drug discovery and development of transformative medicine; and AffaMed Therapeutics Shanghai Ltd, raising $170 million in series B round of financing to further develop its Ophthalmic and Neuroscience pipeline are the major VC deals reported in March 2021.

Deal Date

Acquirer (s) Target

Deal Value ($ m)

15-Mar-21 F2 Ventures Limited; Itochu Technology Ventures, Inc.; Invus Group LLC; EcoR1 Capital LLC; Redmile Group LLC; Fidelity Management & Research Company; EDBI Pte Ltd; Emerson Collective LLC; Vertex Ventures HC; MPM Capital Inc; Matrix Capital Management Fund LP; SoftBank Vision Fund LP; Samsara BioCapital LLC; Surveyor Capital Ltd; Undisclosed ElevateBio LLC (US) 525.0
15-Mar-21 BlackRock Inc; Canada Pension Plan Investment Board; Undisclosed; Third Rock Ventures LLC; Alexandria Venture Investments; Temasek Holdings (HK) Limited; ARCH Venture Partners LP; Andreessen Horowitz LLC; Foresite Capital Management LLC; Two Sigma Ventures LP; Casdin Capital LLC; HOF Capital; GV Management Co LLC; T Rowe Price Associates Inc; SoftBank Investment Advisors Insitro Inc (US) 400.0
30-Mar-21 Central Bottling Company, Ltd.; Partners Investment; Fountainhead Investment Partners, LLC; Lake Bleu Capital; Superstring Capital Management LP; Orion Science Capital AffaMed Therapeutics Shanghai Ltd (China) 170.0
17-Mar-21 M&G Investment Management Ltd; Tencent Holdings Ltd; Gilead Sciences Inc; Oxford Sciences Innovation Plc; Future Planet Capital; Fonds de Reserve Constitutionnel Vaccitech Ltd (United Kingdom) 168.0
3-Mar-21 Orbimed Advisors LLC; RA Capital Management LP; Marshall Wace LLP; Fidelity Management & Research Company; Versant Venture Management LLC; Qatar Investment Authority; Federated Kaufmann Fund; Octagon Capital Group LLC; Casdin Capital LLC; Leaps by Bayer; Logos Global Management LLC; Avidity Partners LLC Century Therapeutics Inc (US) 160.0

Source: GlobalData

Leave A Reply

Your email address will not be published.

 Introducing Smart Autoinjector: Changing the paradigm of usability, cost & size
Know More?
close-image
Attend India's Largest Pharma Packaging & Labelling Conclave
Register Now
close-image